These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3015143)

  • 41. 2',3'-dideoxycytidine permeation of the human erythrocyte membrane.
    Magnani M; Bianchi M; Rossi L; Stocchi V
    Biochem Int; 1989 Aug; 19(2):227-34. PubMed ID: 2554906
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Substances affecting the infection and replication of human immunodeficiency virus (HIV).
    Yamamoto N; Harada S; Nakashima H
    AIDS Res; 1986 Dec; 2 Suppl 1():S183-9. PubMed ID: 3030346
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of human immunodeficiency virus (HIV-1/HTLV-IIIBa-L) replication in fresh and cultured human peripheral blood monocytes/macrophages by azidothymidine and related 2',3'-dideoxynucleosides.
    Perno CF; Yarchoan R; Cooney DA; Hartman NR; Gartner S; Popovic M; Hao Z; Gerrard TL; Wilson YA; Johns DG
    J Exp Med; 1988 Sep; 168(3):1111-25. PubMed ID: 2844951
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Structure of HTLV and its biological function in leukemogenesis of adult T-cell leukemia.
    Miwa M; Shimotohno K; Takano M; Shima H; Watanabe S; Tosu M; Sekiguchi T; Shimoyama M; Sugimura T
    AIDS Res; 1986 Dec; 2 Suppl 1():S61-70. PubMed ID: 2881557
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The in vitro and in vivo anti-retrovirus activity, and intracellular metabolism of 3'-azido-2',3'-dideoxythymidine and 2',3'-dideoxycytidine are highly dependent on the cell species.
    Balzarini J; Pauwels R; Baba M; Herdewijn P; de Clercq E; Broder S; Johns DG
    Biochem Pharmacol; 1988 Mar; 37(5):897-903. PubMed ID: 2830886
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of human T-cell lymphotropic virus type III in vitro by phosphonoformate.
    Sandstrom EG; Kaplan JC; Byington RE; Hirsch MS
    Lancet; 1985 Jun; 1(8444):1480-2. PubMed ID: 2409414
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preliminary pharmacokinetics of 2',3'-dideoxycytidine in neonatal goats.
    Williams RJ; Knight AP; Smith JA; Boudinot FD; Demartini JC; Dahlberg JE
    J Vet Pharmacol Ther; 1989 Sep; 12(3):334-9. PubMed ID: 2553996
    [No Abstract]   [Full Text] [Related]  

  • 48. Immunohistochemical variation of human equilibrative nucleoside transporter 1 protein in primary breast cancers.
    Mackey JR; Jennings LL; Clarke ML; Santos CL; Dabbagh L; Vsianska M; Koski SL; Coupland RW; Baldwin SA; Young JD; Cass CE
    Clin Cancer Res; 2002 Jan; 8(1):110-6. PubMed ID: 11801546
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity.
    Sodroski J; Goh WC; Rosen C; Campbell K; Haseltine WA
    Nature; 1986 Jul 31-Aug 6; 322(6078):470-4. PubMed ID: 3016552
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay.
    Harada S; Koyanagi Y; Yamamoto N
    Science; 1985 Aug; 229(4713):563-6. PubMed ID: 2992081
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Follow-up of neuropathy from 2',3'-dideoxycytidine.
    Dubinsky RM; Dalakas M; Yarchoan R; Broder S
    Lancet; 1988 Apr; 1(8589):832. PubMed ID: 2895352
    [No Abstract]   [Full Text] [Related]  

  • 52. 1-beta-D-arabinofuranosylcytosine metabolism and incorporation into DNA as determinants of in vivo murine tumor cell response.
    Riva CM; Rustum YM
    Cancer Res; 1985 Dec; 45(12 Pt 1):6244-9. PubMed ID: 2998596
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Metabolism and chemotherapeutic activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia L1210 and evidence for its phosphorylation by deoxycytidine kinase.
    Brockman RW; Cheng YC; Schabel FM; Montgomery JA
    Cancer Res; 1980 Oct; 40(10):3610-5. PubMed ID: 6254636
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Implications of the discovery of HTLV-III for the treatment of AIDS.
    Yarchoan R; Mitsuya H; Matsushita S; Broder S
    Cancer Res; 1985 Sep; 45(9 Suppl):4685s-4688s. PubMed ID: 2410113
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Construction and characterization of deltaretrovirus indicator cell lines.
    Jewell NA; Mansky LM
    J Virol Methods; 2005 Jan; 123(1):17-24. PubMed ID: 15582694
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antiviral effects of 3'-azido-3'-deoxythymidine, 2',3'-dideoxycytidine, and 2',3'-dideoxyadenosine against simian acquired immunodeficiency syndrome-associated type D retrovirus in vitro.
    Tsai CC; Follis KE; Benveniste RE
    AIDS Res Hum Retroviruses; 1988 Oct; 4(5):359-68. PubMed ID: 2461724
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Selective uptake of [125I]iododeoxycytidine in cells infected with herpes simplex virus type 1.
    Laskin OL; Griffin DE; Lietman PS
    J Infect Dis; 1981 Jul; 144(1):78. PubMed ID: 6267144
    [No Abstract]   [Full Text] [Related]  

  • 58. A novel affinity chromatography method for the co-purification of deoxycytidine kinase and cytidine deaminase.
    Uchida H; Morinaga H; Misaki T; Miyazaki T; Uwajima T; Obata T; Endo Y; Matsuda A; Sasaki T
    Nucleosides Nucleotides Nucleic Acids; 2001 Sep; 20(9):1647-54. PubMed ID: 11580191
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic.
    Broder S
    Antiviral Res; 2010 Jan; 85(1):1-18. PubMed ID: 20018391
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Establishment of a rodent model of HIV-associated sensory neuropathy.
    Keswani SC; Jack C; Zhou C; Höke A
    J Neurosci; 2006 Oct; 26(40):10299-304. PubMed ID: 17021185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.